Valerian root works primarily by amplifying the activity of GABA, the brain’s main calming neurotransmitter. Its key active compound, valerenic acid, binds directly to GABA receptors at a specific site, making them more responsive to the GABA your brain already produces. This is the same general system targeted by prescription sedatives and anti-anxiety medications, though valerian’s effects are considerably milder.
How Valerenic Acid Affects Your Brain
Your brain regulates alertness and relaxation through a balance of excitatory and inhibitory signals. GABA is the primary inhibitory neurotransmitter: when it binds to GABA-A receptors on nerve cells, it opens chloride channels that make neurons less likely to fire. The result is a quieting effect on brain activity, which is why drugs that enhance GABA signaling tend to reduce anxiety and promote sleep.
Valerenic acid, the most studied compound in valerian root, binds to GABA-A receptors with high affinity at the nanomolar level, meaning it locks on at very low concentrations. Rather than replacing GABA, it enhances the receptor’s response to GABA that’s already present. Researchers at the University of Illinois identified the precise binding location on a specific subunit of the receptor (called β3). When they introduced a single mutation at that site, valerenic acid’s effects dropped sharply, confirming that this is the molecular target responsible for the plant’s calming properties. Neurons containing β3-type GABA-A receptors appear to be the primary cellular pathway for valerian’s anti-anxiety action.
Valerian also stimulates the enzyme that produces GABA in the brain (glutamic acid decarboxylase, or GAD), boosting its activity by over 40% in lab conditions. More GABA production combined with more sensitive GABA receptors creates a two-pronged effect on the same calming system.
Why Products Vary So Much
Valerian root contains multiple classes of active compounds, and scientists still don’t fully agree on which ones matter most. Beyond valerenic acid, the plant produces compounds called valepotriates, which were originally thought to be the main sedative agents. Animal studies showed that valepotriates decreased spontaneous movement, supporting a sedative role. But valepotriates are unstable: they break down during drying and storage, and they don’t dissolve in water. That breakdown is actually what produces valerian’s distinctive, pungent smell.
Safety concerns added another reason to move away from valepotriates. Studies found they could be mutagenic, so most commercial extracts shifted to water-based preparations standardized for valerenic acid content instead. This means different valerian products can have very different chemical profiles depending on the species used, when the plant was harvested, and how it was processed. The NIH notes that levels of active constituents “vary significantly among plants depending on when the plants are harvested, resulting in marked variability in the amounts found in valerian preparations.” Two bottles on the same shelf may not deliver the same experience.
What the Clinical Evidence Shows
In one randomized, double-blind trial, 75 people with insomnia took either 600 mg of valerian extract or 10 mg of oxazepam (a benzodiazepine sedative) daily for 28 days. Both groups saw significant improvements in sleep quality, and there was no statistical difference between the two treatments. The effect sizes between groups ranged from 0.02 to 0.25, meaning valerian performed essentially on par with the pharmaceutical option in this population of otherwise healthy insomniacs.
For anxiety, a 2002 comparative study found that valerian and diazepam both produced significant reductions on the psychological distress portion of a standard anxiety rating scale. That said, the NIH considers the overall evidence for valerian’s effectiveness in sleep disorders “inconclusive,” largely because studies have used different doses, different preparations, measured different outcomes, and often had small sample sizes with high dropout rates. The evidence is promising but not airtight.
Effects on Sleep Stages
Valerian doesn’t just make you drowsy. It appears to shift the balance between types of sleep. Research using brain-wave monitoring found that valerian extract increased non-REM sleep (the deeper, more restorative phases) while decreasing the proportion of REM sleep. It also increased the density and frequency of sleep spindles, which are brief bursts of brain activity during lighter non-REM stages associated with memory consolidation and sleep stability. For people whose sleep feels light or fragmented, this shift toward deeper sleep architecture could explain why they wake up feeling more rested.
How Long Before It Works
Valerian is not a fast-acting knockout pill. Most clinical trials that showed benefits used daily dosing over two to four weeks. The 28-day oxazepam comparison study, for example, measured outcomes at the end of a full month of use. Some people report noticing mild relaxation on the first night, but the fuller sleep-quality benefits appear to build with consistent use over time. If you try it once and feel nothing, that’s typical rather than a sign it won’t work for you.
Drug Interactions Worth Knowing
Valerian root inhibits CYP3A4, a liver enzyme responsible for metabolizing over 70% of common medications. When this enzyme is suppressed, drugs that rely on it for breakdown can build up to higher-than-expected levels in your bloodstream. Lab studies on commercial valerian products confirmed a “marked capacity” to inhibit CYP3A4 activity. There’s also evidence of a biphasic pattern: valerian may inhibit the enzyme shortly after you take it but potentially induce (speed up) the enzyme if it’s in your system for a longer window. This makes the interaction profile somewhat unpredictable, especially if you take medications for blood pressure, cholesterol, heart rhythm, or immune suppression, all of which commonly depend on CYP3A4 for processing.
Side Effects and Safety
In controlled trials, valerian’s side effect profile has been mild. In the 28-day comparison study, two people in the valerian group withdrew due to possible adverse reactions compared to three in the pharmaceutical group, and no serious adverse events occurred in either group. The most commonly reported issues are headache, digestive discomfort, and grogginess the next morning.
The bigger safety question is product quality. Because valerian is sold as a dietary supplement, it isn’t subject to the same manufacturing standards as prescription drugs. The wide natural variability in active compounds, combined with the instability of valepotriates during processing, means you’re relying heavily on the manufacturer’s quality control. Choosing products that are standardized for valerenic acid content and third-party tested gives you a better chance of getting a consistent dose.